Skip to content
The Policy VaultThe Policy Vault

migalastat hclBlue Cross Blue Shield of Montana

Fabry disease

Initial criteria

  • Quantity limit for the Target Agent(s) will be approved when ONE of the following is met:
  • 1. The requested quantity (dose) does NOT exceed the program quantity limit OR
  • 2. The requested quantity (dose) exceeds the program quantity limit AND ONE of the following:
  • A. BOTH of the following:
  • 1. The requested agent does NOT have a maximum FDA labeled dose for the requested indication AND
  • 2. There is support for therapy with a higher dose for the requested indication OR
  • B. BOTH of the following:
  • 1. The requested quantity (dose) does NOT exceed the maximum FDA labeled dose for the requested indication AND
  • 2. There is support for why the requested quantity (dose) cannot be achieved with a lower quantity of a higher strength that does NOT exceed the program quantity limit

Approval duration

6–12 months